Description of Collaborative Activity: |
As a part of the HHS strategic plan for blood and tissue safety, the taskforce is charged with reviewing the potential of pathogen reduction technologies that are designed inactivate pathogens in blood supply. Current surveillance systems detect threats, but the lag between detection and action continues to place recipients at risk. The taskforce seeks to address questions and challenges in transfusion safety, barriers to technological advancement, safety gaps related to pathogen reduction. |
